Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Sub-Saharan Africa
100%
Gastroenteritis
100%
Vaccine Effectiveness
100%
Rotavirus Gastroenteritis
100%
Pentavalent Rotavirus Vaccine
100%
Efficacy Endpoint
100%
African Countries
40%
Etiology
40%
First Year of Life
40%
Severe Gastroenteritis
20%
Africa
20%
Placebo
20%
Rotavirus Genotypes
20%
Subgroup Analysis
20%
Low-income Countries
20%
Placebo-controlled
20%
Public Health Importance
20%
G-type
20%
RotaTeq
20%
Disease Severity
20%
Ghana
20%
In(III)
20%
Kenya
20%
EPI Vaccines
20%
Concomitant Administration
20%
HIV-exposed Infants
20%
Mali
20%
Scoring System
20%
Under-five Mortality
20%
Phase I Trial
20%
Medicine and Dentistry
Gastroenteritis
100%
Rotavirus Vaccine
100%
Rotavirus
75%
Vaccine Efficacy
62%
Placebo
25%
Etiology
25%
Human Immunodeficiency Virus
12%
Clinical Trial
12%
Public Health
12%
Mortality Rate
12%
Disease Severity
12%
Subgroup Analysis
12%
Scoring System
12%
Pharmacology, Toxicology and Pharmaceutical Science
Gastroenteritis
100%
Rotavirus Vaccine
100%
Rotavirus
75%
Vaccine Efficacy
62%
Placebo
25%
Etiology
25%
Clinical Trial
12%
HIV
12%
Mortality Rate
12%
Disease Severity
12%
Immunology and Microbiology
Rotavirus Vaccine
100%
Gastroenteritis
100%
Rotavirus
75%
Vaccine Efficacy
62%
Human Immunodeficiency Virus
12%
Mortality Rate
12%
Biochemistry, Genetics and Molecular Biology
Rotavirus
100%
Human Immunodeficiency Virus
9%
Clinical Trial
9%
Mortality Rate
9%
Veterinary Science and Veterinary Medicine